BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33484728)

  • 1. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
    Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
    Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering of lung diseases in the family of interstitial lung disease patients.
    Terwiel M; Grutters JC; van Moorsel CHM
    BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
    Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
    Hunninghake GM; Quesada-Arias LD; Carmichael NE; Martinez Manzano JM; Poli De Frías S; Baumgartner MA; DiGianni L; Gampala-Sagar SN; Leone DA; Gulati S; El-Chemaly S; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO
    Am J Respir Crit Care Med; 2020 May; 201(10):1240-1248. PubMed ID: 32011908
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.
    Ikezoe K; Handa T; Tanizawa K; Chen-Yoshikawa TF; Kubo T; Aoyama A; Motoyama H; Hijiya K; Tokuda S; Nakatsuka Y; Yamamoto Y; Oshima A; Harashima SI; Nagai S; Hirai T; Date H; Chin K
    PLoS One; 2017; 12(8):e0183171. PubMed ID: 28800589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
    Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
    Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
    [No Abstract]   [Full Text] [Related]  

  • 10. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
    Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
    BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
    King CS; Ignacio RV; Khangoora V; Nyquist A; Singhal A; Thomas C; Cantres OF; Aryal S; Shlobin OA; Flaherty K; Lasky J; Nathan SD
    Am J Respir Crit Care Med; 2024 Jan; ():. PubMed ID: 38236191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
    Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
    Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease.
    Han SJ; Kim HH; Hyun DG; Ji W; Choi CM; Lee JC; Kim HC
    BMC Pulm Med; 2024 Mar; 24(1):136. PubMed ID: 38491506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.